title: Pediatric tuberculosis drug market: an insider perspective on challenges and solutions.
abstract: Representative stakeholders were consulted on how they felt access to pediatric tuberculosis (TB) drugs could be improved. A key recommendation is the development of new child-friendly, adequately dosed formulations with a good shelf life in all climate zones. There is also an urgent need to improve the diagnosis and reporting of children with TB. Manufacturers of pediatric TB medications are to be incentivized through improved coordination among all stakeholders, with streamlined regulatory approvals and increased consumer education on drug and regimen guidelines. Finally, pooled procurement is advised to ensure sustained market supply against affordable prices.
authors.affiliation: The Global Alliance for TB Drug Development, New York, New York.
authors.forename: I
authors.initials: I
authors.lastname: Usherenko
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: U
authors.initials: U
authors.lastname: Basu Roy
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: S
authors.initials: S
authors.lastname: Mazlish
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: S
authors.initials: S
authors.lastname: Liu
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: L
authors.initials: L
authors.lastname: Benkoscki
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: D
authors.initials: D
authors.lastname: Coutts
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: S
authors.initials: S
authors.lastname: Epstein
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: M
authors.initials: M
authors.lastname: Qian
authors.affiliation: The Solutions Lab, New York University, New York, New York, USA.
authors.forename: S
authors.initials: S
authors.lastname: Rafiq
authors.forename: C
authors.initials: C
authors.lastname: Scott
mesh_terms: D000995:Antitubercular Agents / Q000191:economics* / Q000600:supply & distribution*; D002648:Child; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D017410:Practice Guidelines as Topic; D014376:Tuberculosis / Q000188:drug therapy* / Q000191:economics*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents